Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Revenue (2016 - 2025)

Dare Bioscience's Revenue history spans 9 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Revenue rose 1708.36% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 10429.36%, while the annual FY2025 figure was $1.0 million, 10429.36% up from the prior year.
  • Revenue reached $1.0 million in Q4 2025 per DARE's latest filing, up from $2262.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $10.0 million in Q2 2022 to a low of -$63647.0 in Q4 2024.
  • Average Revenue over 4 years is $1.3 million, with a median of $25427.0 recorded in 2025.
  • The largest YoY upside for Revenue was 1708.36% in 2025 against a maximum downside of 194.36% in 2025.
  • A 4-year view of Revenue shows it stood at $10.0 million in 2022, then tumbled by 81.92% to $1.8 million in 2023, then tumbled by 103.52% to -$63647.0 in 2024, then skyrocketed by 1708.36% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Revenue are $1.0 million (Q4 2025), $2262.0 (Q3 2025), and -$21172.0 (Q2 2025).